Integration of Genomic Data Enables Selective Discovery of Breast Cancer Drivers

[1]  Janos X. Binder,et al.  DISEASES: Text mining and data integration of disease–gene associations , 2014, bioRxiv.

[2]  María Martín,et al.  Activities at the Universal Protein Resource (UniProt) , 2013, Nucleic Acids Res..

[3]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[4]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[5]  D. Pe’er,et al.  RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation. , 2013, Cancer research.

[6]  W. M. Leevy,et al.  Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix. , 2013, Cancer research.

[7]  Pablo Tamayo,et al.  ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens , 2013, Genome research.

[8]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[9]  S. Elledge,et al.  A role for PVRL4-driven cell–cell interactions in tumorigenesis , 2013, eLife.

[10]  I. Shih,et al.  Rsf‐1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development , 2013, The Journal of pathology.

[11]  Lao H. Saal,et al.  Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells , 2013, Cancer biology & therapy.

[12]  The UniProt Consortium,et al.  Update on activities at the Universal Protein Resource (UniProt) in 2013 , 2012, Nucleic Acids Res..

[13]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[14]  Junying Zhang,et al.  Comparative Analysis of Methods for Identifying Recurrent Copy Number Alterations in Cancer , 2012, PloS one.

[15]  W. Kaelin,et al.  Use and Abuse of RNAi to Study Mammalian Gene Function , 2012, Science.

[16]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[17]  A. Sivachenko,et al.  Sequence analysis of mutations and translocations across breast cancer subtypes , 2012, Nature.

[18]  A. Børresen-Dale,et al.  The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.

[19]  E. Wang,et al.  Rsf-1 overexpression correlates with poor prognosis and cell proliferation in colon cancer , 2012, Tumor Biology.

[20]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[21]  E. Wang,et al.  Rsf-1 is overexpressed in non-small cell lung cancers and regulates cyclinD1 expression and ERK activity. , 2012, Biochemical and biophysical research communications.

[22]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[23]  Eric S. Lander,et al.  Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing , 2012, Proceedings of the National Academy of Sciences.

[24]  Kevin R Brown,et al.  Essential gene profiles in breast, pancreatic, and ovarian cancer cells. , 2012, Cancer discovery.

[25]  Xin-Yun Huang,et al.  Mouse models for tumor metastasis. , 2012, Methods in molecular biology.

[26]  Hai-feng Yu,et al.  High RSF-1 expression correlates with poor prognosis in patients with gastric adenocarcinoma. , 2012, International journal of clinical and experimental pathology.

[27]  Chien-Feng Li,et al.  Rsf‐1/HBXAP overexpression is associated with disease‐specific survival of patients with gallbladder carcinoma , 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[28]  Michele Ceccarelli,et al.  Finding recurrent copy number alterations preserving within-sample homogeneity , 2011, Bioinform..

[29]  J. Mesirov,et al.  Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer , 2011, Proceedings of the National Academy of Sciences.

[30]  Hannah Carter,et al.  CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer , 2011, Bioinform..

[31]  I. Shih,et al.  Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma. , 2011, The American journal of pathology.

[32]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[33]  A. Ashworth,et al.  Genetic Interactions in Cancer Progression and Treatment , 2011, Cell.

[34]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[35]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[36]  Andrew B. Nobel,et al.  DiNAMIC: a method to identify recurrent DNA copy number aberrations in tumors , 2010, Bioinform..

[37]  S. De,et al.  DNA secondary structures and epigenetic determinants of cancer genome evolution , 2010, Nature Structural &Molecular Biology.

[38]  D. Pe’er,et al.  An Integrated Approach to Uncover Drivers of Cancer , 2010, Cell.

[39]  Calum MacAulay,et al.  Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma , 2010, PLoS medicine.

[40]  A. Lal,et al.  MicroRNAs and their target gene networks in breast cancer , 2010, Breast Cancer Research.

[41]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[42]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[43]  Stephen J. Elledge,et al.  Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening , 2008, Science.

[44]  A. Joe,et al.  Oncogene addiction. , 2008, Cancer research.

[45]  E. Lander,et al.  Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.

[46]  Ian Collins,et al.  New approaches to molecular cancer therapeutics , 2006, Nature chemical biology.

[47]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Giovanni Parmigiani,et al.  Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Albertson,et al.  Chromosome aberrations in solid tumors , 2003, Nature Genetics.

[50]  D. Medina,et al.  A clonal derivative of mammary epithelial cell line COMMA-D retains stem cell characteristics of unique morphological and functional heterogeneity. , 1988, Experimental cell research.

[51]  J. Dahlberg,et al.  Molecular biology. , 1977, Science.

[52]  H. D. Brunk.  Maximum Likelihood Estimates of Monotone Parameters , 1955 .